Neuropathic pain: implications for the surgeon.
Pharmacologic therapy for neuropathic pain is based on an evolving understanding of its underlying mechanisms, and often requires a patient,methodical sequence of trials that include the "four As": analgesics,antidepressants, anticonvulsants, and antiarrhythmics. Critical for success is a willingness to stay engaged with the patient to evolve a mutually acceptable plan and goals of care with realistic outcomes that emphasize symptom control and maximization of function. Such management is within the capabilities of surgeons for most patients, whereas the use of consultation and interdisciplinary supportive interventions from comprehensive pain management centers, if available, is helpful in more difficult cases.
Milch
Robert A
RA
State University of Buffalo, Buffalo, NY, USA. rmilch@palliativecare.org
D000700:Analgesics / Q000627:therapeutic use; D000777:Anesthetics / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D013502:General Surgery; D006801:Humans; D009437:Neuralgia / Q000188:drug therapy*; D010149:Postoperative Pain / Q000188:drug therapy*; D010166:Palliative Care
D000700:Analgesics; D000777:Anesthetics; D000927:Anticonvulsants; D000928:Antidepressive Agents